NEW YORK (GenomeWeb) – Nuclea Biotechnologies said today that it is partnering with the Institut de recherches cliniques de Montréal (IRCM) to validate mass spec assays for insulin, proinsulin, and c-peptide.

Under the partnership the two companies will run the assays on clinical sample cohorts at both Nuclea and IRCM's facilities to test the precision, sensitivity, and reproducibility of the assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.